Journey of Coffee | Coffee Patents in India

Journey of Coffee | Coffee Patents in India

Journey of Coffee in patents are related in several ways, particularly in the context of innovations and technologies related to coffee production, preparation, and equipment.

Interesting journey of Coffee

Coffee is a popular beverage enjoyed by millions of people around the world. It is made from roasted coffee beans, which are the seeds of the Coffea plant. Coffee is known for its stimulating effects due … Read More

Understanding Patent in simple terms

Understanding Patent in simple terms

Understanding patents can be a complex topic, this article will break down patent definition and meaning into more manageable concepts for you.

What is Patent?

A patent provides a legal protection by the government to applicant/inventors for their new and useful inventions. In simple terms, applicant/inventor obtains exclusive rights to make, use, and sell their invention for a certain period, usually 20 years from the … Read More

Fintech Innovations – Shaping the future of Financial Services

Fintech innovation covers a wide range of technological advancements and developments in the financial industry. Certainly, the field of fintech (financial technology) has been rapidly evolving and experiencing numerous innovations.

Fintech innovations provides financial products and services, that disrupts traditional financial systems, and improve the efficiency of financial transactions.

Some of the notable fintech innovations that were shaping the fintech landscape are as follows:

  • Blockchain:
Read More

CONTROVERSIAL PATENTS IN INDIA

CONTROVERSIAL PATENTS IN INDIA

Controversial patents in India includes patents surrounded by controversies due to various reasons like disputes over patent validity, infringement, ethical concerns, public health implications, and more.

SOME OF THE MOST CONTROVERSIAL PATENTS IN INDIA

Novarti‘s Gleevec Patent: Cancer drug controversial patent

In 2013, the Indian Supreme Court rejected Novartis’ patent application for the cancer drug Gleevec (Imatinib Mesylate). The decision was significant as it … Read More